BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Denator AB Announces Kit to Assist in Detection of Endogenous Peptides


5/24/2011 10:21:53 AM

Gothenburg, Sweden, 24 May 2011: Denator AB announced today that it has launched the first in a series of kits designed for use with the company’s heat-stabilization system. The Stabilizor™ Peptide Extraction Kit enables users to heat-stabilize, homogenize and extract endogenous peptides from tissue samples prior to analysis by liquid chromatography-mass spectrometry (LC-MS).

During downstream analysis, the presence of endogenous peptides, often existing at very low levels in vivo, can be masked by peptide fragments generated from normal degradation processes. Utilization of Denator’s Stabilizor system, based on the company’s heat-stabilization technology, has been shown to stop tissue degradation from the moment of sampling, preventing the enzymatic processes that generate peptide fragments.

This news will be of particular interest to researchers looking at the role of neuropeptides in neurogenerative diseases. A recently published paper demonstrated an increased recovery of neuropeptides from tissue samples when utilizing heat stabilization followed by an optimal extraction protocol (Neuropeptide profiling of the bovine hypothalamus: Thermal stabilization is an effective tool in inhibiting post-mortem degradation. Michelle L. Colgrave, et al., Proteomics 2011, 11, 1-13.).

Olof Sköld, CEO at Denator, explained further: “Working closely with users of our system has revealed that the quality of final results can be influenced by the extraction methods used after heat stabilization. This new kit offers the convenience of having all necessary accessories and solutions ready to use, and, most importantly, includes a validated protocol that aims to maximize the recovery of endogenous, water-soluble peptides for subsequent analysis by LC-MS. We see this development as a natural step to ensure that researchers who heat-stabilize tissues upstream achieve the best possible analytical results downstream.”

Implementation of the Stabilizor solution in laboratory workflows is reflected in a growing number of peer-reviewed publications particularly from proteomic laboratories. Scientists are able to perform many analyses without risk of sample degradation, confident that their results truly reflect the in vivo situation.

HEAR MORE: Users of Denator’s novel heat-stabilization solution will be presenting their work during the upcoming meeting of the American Society of Mass Spectrometry (ASMS) in Denver, Colorado.

Enquiries:

Olof Sköld, CEO

Tel: +46 (0)707918335

Email: olof.skold@denator.com

About Denator AB

www.denator.com

Denator AB is a privately held biotech company based in Gothenburg, Sweden. Denator develops and markets products that stabilize biological tissues and fluids from the moment of sampling. Stabilization and standardization of sampling processes upstream significantly enhances the quality of data obtained from analytical techniques used downstream. Based upon the company’s proprietary heat inactivation technology platform, Denator is developing solutions that enable scientists to stop sample degradation instantly and so maintain the stability of sample components throughout the analytical workflow.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES